ABT: Abbott Laboratories Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABT: Abbott Laboratories

ABT 125.10

+0.5%

11:25 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: HerbVic who wrote (15)	7/1/2003 3:47:40 PM
From: HerbVic	Read Replies (1) of 33

Abbott Laboratories "top pick" Monday, June 30, 2003 6:15:50 AM ET RBC Capital Markets NEW YORK, June 30 (New Ratings) - Analysts at RBC Capital Markets issue a "top pick" rating on Abbott Laboratories (ABT). The target price is set to $55. In a research note published on June 27, the analysts mention that Abbott’s Ross division is involved in an investigation by the US Attorney’s Office into the enteral nutrition business. According to the analysts, the company plans to record a $622 million one-time charge as settlement of all outstanding claims related to the investigation. Abbott has enough cash reserves for the purpose, the analysts believe. The company is expected to generate further free cash flow of $1.5 billion this year, says RBC Capital Markets. © 2003 New Ratings newratings.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next